v3.26.1
Subsequent Events (Details) - USD ($)
$ / shares in Units, $ in Millions
1 Months Ended 6 Months Ended
Aug. 03, 2026
Aug. 01, 2026
Jul. 31, 2026
Aug. 06, 2026
Jul. 31, 2026
Jul. 31, 2025
Jun. 30, 2026
Jul. 28, 2026
Jul. 27, 2026
Jul. 08, 2026
Jul. 02, 2026
Dec. 31, 2025
Aug. 31, 2025
Jan. 17, 2025
Feb. 01, 2021
Subsequent Event [Line Items]                              
Proceeds from marketable securities           $ 2.9 $ 0.6                
Series A-3 and A-4 Preferred Stock                              
Subsequent Event [Line Items]                              
Redemption value             9.7                
R2 Technologies                              
Subsequent Event [Line Items]                              
Controlling interest (approximately)                       81.00%      
Subsequent Event                              
Subsequent Event [Line Items]                              
Declared cash dividend receivable       $ 12.0           $ 12.0          
Proceeds from dividends received $ 11.0                            
Proceeds from marketable securities       $ 0.6 $ 0.6                    
Subsequent Event | R2 Technologies                              
Subsequent Event [Line Items]                              
Controlling interest (approximately)               85.00% 80.80%            
Life Sciences | MediBeacon Inc. | Notes Receivable                              
Subsequent Event [Line Items]                              
Accrued interest receivable             $ 0.4         $ 0.4      
Life Sciences | Subsequent Event | MediBeacon Inc. | Notes Receivable, Maturity of July 5, 2026                              
Subsequent Event [Line Items]                              
Notes receivable, face amount                     $ 0.5        
Life Sciences | Subsequent Event | MediBeacon Inc. | Notes Receivable                              
Subsequent Event [Line Items]                              
Notes receivable, face amount                     0.9        
Accrued interest receivable                     $ 0.4        
Interest rate                     8.00%        
Notes receivable convertible conversion price discount percentage                     20.00%        
Convertible notes receivable, conversion price                     $ 74.00        
Convertible Debt | Life Sciences | MediBeacon Inc.                              
Subsequent Event [Line Items]                              
Notes receivable, face amount                           $ 11.4  
Accrued interest receivable                           $ 1.5  
10.50% Senior Secured Notes | Secured Debt | Subsequent Event                              
Subsequent Event [Line Items]                              
Interest rate 10.50%   10.50%   10.50%                    
Consent fee percentage   1.50% 1.50%   1.50%                    
Interest paid $ 3.1 $ 3.6                          
Expected interest due 19.9 $ 22.6                          
Outstanding debt 400.9                            
10.50% Senior Secured Notes | Secured Debt | Non-Operating Corporate                              
Subsequent Event [Line Items]                              
Interest rate             10.50%           10.50%    
Face amount                         $ 360.4    
Outstanding debt             $ 379.3         360.4      
10.50% Senior Secured Notes | Secured Debt | Non-Operating Corporate | Subsequent Event                              
Subsequent Event [Line Items]                              
Interest rate   10.50%                          
Lancer Promissory Note | R2 Technologies                              
Subsequent Event [Line Items]                              
Face amount             50.9                
Lancer Promissory Note | Senior Notes | Life Sciences                              
Subsequent Event [Line Items]                              
Outstanding debt             50.9         47.9      
2026 Convertible Notes | Secured Debt | Subsequent Event                              
Subsequent Event [Line Items]                              
Face amount   $ 0.2                          
2027 Convertible Notes | Secured Debt | Subsequent Event                              
Subsequent Event [Line Items]                              
Consent fee percentage     1.50%   1.50%                    
Interest paid 0.5                            
Expected interest due 2.7                            
Outstanding debt $ 58.9                            
2027 Convertible Notes | Secured Debt | Subsequent Event | Lancer Capital                              
Subsequent Event [Line Items]                              
Repayments of debt     $ 0.1                        
7.50% Convertible Senior Notes                              
Subsequent Event [Line Items]                              
Outstanding debt             $ 0.2                
7.50% Convertible Senior Notes | Subsequent Event                              
Subsequent Event [Line Items]                              
Outstanding debt   0.2                          
Principal amount   $ 0.2                          
7.50% Convertible Senior Notes | Non-Operating Corporate                              
Subsequent Event [Line Items]                              
Interest rate             7.50%                
Outstanding debt                       0.2      
7.50% Convertible Senior Notes | Secured Debt | Non-Operating Corporate                              
Subsequent Event [Line Items]                              
Interest rate                             7.50%
7.50% Convertible Senior Notes | Convertible Debt | Subsequent Event                              
Subsequent Event [Line Items]                              
Interest rate   7.50%                          
7.50% Convertible Senior Notes | Convertible Debt | Non-Operating Corporate                              
Subsequent Event [Line Items]                              
Interest rate                             7.50%
Outstanding debt             $ 0.2         $ 0.2